News

Genomic Health has declared results from the first study to compare the distribution of Oncotype DX Recurrence Score results between European, Middle Eastern and the US patient populations.

Amgen has detailed its results from a phase 3, head-to-head trial evaluating denosumab versus Zometa in the treatment of bone metastases. The trial was conducted in 2,046 patients

Roche has revealed an analysis of its phase II BRAIN study of Avastin (bevacizumab) alone or in combination with irinotecan chemotherapy for the treatment of relapsed or progressive

Boehringer Ingelheim with its US animal health business Boehringer Ingelheim Vetmedica, has entered into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceutical’s Fort Dodge Animal

AIDS Healthcare Foundation (AHF) has disclosed its plans to open its first AIDS treatment center in Washington, DC, on September 24, 2009. AHF’s health care center, to be

ACTEGA Rhenania has developed a novel series of solvent-free polyurethane adhesives for laminates to be used in packaging. Compared to classical solvent-borne polyurethane adhesives there is no need

Nycomed will invest in a state-of-the-art pharmaceutical production plant near the city of Yaroslavl in Russia. The company plans to invest between E65m to E75m. The company said

Nektar Therapeutics presented positive data on lead oncology program, NKTR-102, demonstrating encouraging phase 1 and preclinical anti-tumor activity of the investigational compound in ovarian cancer. These data were

Ion Beam Applications SA (IBA) and Aposense has entered into an collaboration agreement for commercialising Aposense [18F]–ML-10, Aposense’s novel agent for molecular imaging of apoptosis. The agreement includes